Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method

Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., Pickar, D.·1997·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.94.6.2569

Cited by (1,001)

Items 101–200 of 1,001

Dopaminergic dysfunction in alcoholism and schizophrenia—psychopathological and behavioral correlates
Heinz, A. · 2002 · European Psychiatry
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
M. Bossong, B. N. van Berckel, R. Boellaard, L. Zuurman, R. Schuit, A. Windhorst, J. V. van Gerven, N. Ramsey, A. Lammertsma, R. Kahn · 2009 · Neuropsychopharmacology
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging
Oliver D. Howes, A. Egerton, V. Allan, P. McGuire, Paul R. A. Stokes, S. Kapur · 2009 · Current pharmaceutical design
Elevated Intrasynaptic Dopamine Release in Tourette’s Syndrome Measured by PET
Singer, Harvey S., Szymanski, Sally, Giuliano, Joseph, Yokoi, Fuji, Dogan, A. Semih, Brasic, James R., Zhou, Yun, Grace, Anthony A., Wong, Dean F. · 2002 · American Journal of Psychiatry
NMDA receptor regulation of memory and behavior in humans
John W. Newcomer, John Harrison Krystal · 2001 · Hippocampus
The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia.
H. Moore, A. R. West, A. Grace · 1999 · Biological Psychiatry
Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
Egerton, Alice, Chaddock, Christopher A., Winton-Brown, Toby T., Bloomfield, Michael A.P., Bhattacharyya, Sagnik, Allen, Paul, McGuire, Philip K., Howes, Oliver D. · 2013 · Biological Psychiatry
Presynaptic Dopaminergic Dysfunction in Schizophrenia
Stephen McGowan, Andrew D. Lawrence, Tim Sales, Digby J. Quested, Paul M. Grasby · 2004 · Archives of General Psychiatry
Executive Function, Neural Circuitry, and Genetic Mechanisms in Schizophrenia
Daniel Paul Eisenberg, Karen Faith Berman · 2009 · Neuropsychopharmacology
Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects.
P. Strange · 2001 · Pharmacological Reviews
Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
R. de la Fuente-Fernández, Jian-Qiang Lu, V. Sossi, S. Jivan, M. Schulzer, J. E. Holden, Chong S. Lee, Thomas J. Ruth, D. Calne, A. Stoessl · 2001 · Annals of Neurology
The role of the brain reward system in depression
Naranjo, Claudio A., Tremblay, Lescia K., Busto, Usoa E. · 2001 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia
T. Wolinsky, C. Swanson, K. E. Smith, H. Zhong, B. Borowsky, P. Seeman, T. Branchek, C. Gerald · 2007 · Genes, Brain and Behavior
Kinetic modeling in positron emission tomography.
E. Morris, Christopher J. Endres, K. Schmidt, B. Christian, R. F. Muzic, R. Fisher · 2002 · Quarterly Journal of Nuclear Medicine
Dopamine Transmission in the Human Striatum during Monetary Reward Tasks
Zald, David H., Boileau, Isabelle, El-Dearedy, Wael, Gunn, Roger, McGlone, Francis, Dichter, Gabriel S., Dagher, Alain · 2004 · The Journal of Neuroscience
Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor
F. Lee, L. Pei, A. Moszczynska, B. Vukusic, P. Fletcher, Fang Liu · 2007 · EMBO Journal
Brain dopamine is associated with eating behaviors in humans
Volkow, Nora D., Wang, Gene‐Jack, Maynard, Laurence, Jayne, Millard, Fowler, Joanna S., Zhu, Wei, Logan, Jean, Gatley, S. John, Ding, Yu‐Shin, Wong, Christopher et al. · 2003 · International Journal of Eating Disorders
Dopamine hypothesis of schizophrenia: Making sense of it all
Toda, Mitsuru, Abi-Dargham, Anissa · 2007 · Current Psychiatry Reports
Imaging Approaches to Parkinson Disease
David James Brooks · 2010 · Journal of Nuclear Medicine
Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance
Oliver David Howes, Ekaterina Shatalina · 2022 · Biological Psychiatry
Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine
D. Ben-Shachar · 2002 · Journal of Neurochemistry
Dopaminergic basis of salience dysregulation in psychosis
Winton-Brown, Toby T., Fusar-Poli, Paolo, Ungless, Mark A., Howes, Oliver D. · 2014 · Trends in Neurosciences
Sleep in schizophrenia patients and the effects of antipsychotic drugs
Jaime M. Monti, Daniel Monti · 2004 · Sleep Medicine Reviews
N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives
Mark John Millan · 2005 · Psychopharmacology
Altropane, a SPECT or PET imaging probe for dopamine neurons: I. dopamine transporter binding in primate brain
Bertha Kalifon Madras, Peter C. Meltzer, Anna Y. Liang, David R. Elmaleh, John W. Babich, Alan J. Fischman · 1998 · Synapse
Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.
J. Crook, E. Tomaskovic-Crook, D. Copolov, B. Dean · 2001 · American Journal of Psychiatry
Alterations of the Brain Reward System in Antipsychotic Naïve Schizophrenia Patients
Mette Ødegaard Nielsen, Egill Rostrup, Sanne Wulff, Nikolaj Klausholt Bak, Henrik Lublin, Shitij Kapur, Birte Yding Glenthoj · 2012 · Biological Psychiatry
A novel strategy for the treatment of cocaine addiction
Stephen L. Dewey, Alexander E. Morgan, Charles R. Ashby, Bryan Horan, Stephanie A. Kushner, Jean Logan, Nora D. Volkow, Joanna S. Fowler, Eliot L. Gardner, Jonathan D. Brodie · 1998 · Synapse
In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia.
T. Raedler, M. Knable, Douglas W. Jones, R. A. Urbina, J. G. Gorey, K. Lee, M. Egan, R. Coppola, D. Weinberger · 2003 · American Journal of Psychiatry
Transient Overexpression of Striatal D2 Receptors Impairs Operant Motivation and Interval Timing
Michael R. Drew, E. Simpson, C. Kellendonk, William Herzberg, O. Lipatova, Stephen P. Fairhurst, E. Kandel, C. Malapani, P. Balsam · 2007 · Journal of Neuroscience
Molecular substrates of schizophrenia: homeostatic signaling to connectivity
Melissa A. Landek‐Salgado, Travis E. Faust, Akira Sawa · 2015 · Molecular Psychiatry
Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia
Stacy A. Castner, Patricia S. Goldman‐Rakic, GrahamV. Williams · 2004 · Psychopharmacology
Modulators in concert for cognition: Modulator interactions in the prefrontal cortex
Briand, Lisa A., Gritton, Howard, Howe, William M., Young, Damon A., Sarter, Martin · 2007 · Progress in Neurobiology
Reduced prefrontal-parietal effective connectivity and working memory deficits in schizophrenia
Deserno, Lorenz, Sterzer, Philipp, Wüstenberg, Torsten, Heinz, Andreas, Schlagenhauf, Florian · 2012 · The Journal of Neuroscience
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects
Abi-Dargham, Anissa, van de Giessen, Elsmarieke, Slifstein, Mark, Kegeles, Lawrence S., Laruelle, Marc · 2009 · Biological Psychiatry
Alterations of Central Dopamine Receptors Before and After Gastric Bypass Surgery
Steele, Kimberley E., Prokopowicz, Gregory P., Schweitzer, Michael A., Magunsuon, Thomas H., Lidor, Anne O., Kuwabawa, Hiroto, Kumar, Anil, Brasic, James, Wong, Dean F. · 2010 · Obesity Surgery
Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment
Martinez, Diana, Carpenter, Kenneth M., Liu, Fei, Slifstein, Mark, Broft, Allegra, Friedman, Alessandra Calvo, Kumar, Dileep, Van Heertum, Ronald, Kleber, Herbert D., Nunes, Edward · 2011 · American Journal of Psychiatry
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
M. Kokkinou, A. Ashok, O. Howes · 2017 · Molecular Psychiatry
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Michael Bloomfield, Celia J. A. Morgan, Alice Egerton, Shitij Kapur, H. Valerie Curran, Oliver David Howes · 2013 · Biological Psychiatry
Evidence for the Preferential Involvement of 5-HT2A Serotonin Receptors in Stress- and Drug-Induced Dopamine Release in the Rat Medial Prefrontal Cortex
Elizabeth A. Pehek, Christine Nocjar, Bryan L. Roth, Tara A. Byrd, Omar S. Mabrouk · 2005 · Neuropsychopharmacology
Disruption of Neurogenesis on Gestational Day 17 in the Rat Causes Behavioral Changes Relevant to Positive and Negative Schizophrenia Symptoms and Alters Amphetamine-Induced Dopamine Release in Nucleus Accumbens
P. Flagstad, A. Mørk, B. Glenthøj, J. van Beek, A. Michael-Titus, M. Didriksen · 2004 · Neuropsychopharmacology
Advances in schizophrenia
Gunvant K. Thaker, William T. Carpenter · 2001 · Nature Medicine
Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs
T Svensson · 2000 · Brain Research Reviews
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
Poels, E M P, Kegeles, L S, Kantrowitz, J T, Slifstein, M, Javitt, D C, Lieberman, J A, Abi-Dargham, A, Girgis, R R · 2014 · Molecular Psychiatry
Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs.
Jeffrey N. Joyce · 2001 · Pharmacology and Therapeutics
Long‐term follow‐up of cervical dystonia patients treated with botulinum toxin A
Marlene Jiménez del Río, S. Moreno, G. García Ospina, O. Buritica, C. Uribe, F. Lopera, C. Velez-Pardo · 2004 · Movement Disorders
Conditioned cues and the expression of stimulant sensitization in animals and humans
Paul Vezina, Marco Leyton · 2008 · Neuropharmacology
Midbrain dopamine function in schizophrenia and depression: A post-mortem and positron emission tomographic imaging study
Howes, Oliver D., Williams, Matthew, Ibrahim, Kemal, Leung, Garret, Egerton, Alice, McGuire, Philip K., Turkheimer, Federico · 2013 · Brain
The placebo effect in Parkinson's disease
Raúl de la Fuente‐Fernández · 2002 · Trends in Neurosciences
Kinetic Modeling of [11C]Raclopride: Combined PET-Microdialysis Studies
Christopher J. Endres, B. Kolachana, R. Saunders, T. Su, D. Weinberger, A. Breier, W. Eckelman, Richard E. Carson · 1997 · Journal of Cerebral Blood Flow and Metabolism
Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders
Boksa, P., El-Khodor, B.F. · 2003 · Neuroscience & Biobehavioral Reviews
Neurotransmitter interactions in schizophrenia-therapeutic implications
A. Carlsson, N. Waters, M. Carlsson · 1999 · European Archives of Psychiatry and Clinical Neuroscience
Mitochondria, Synaptic Plasticity, And Schizophrenia
Dorit Ben‐Shachar, Daphna Laifenfeld · 2004 · International review of neurobiology
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism
Andrea de Bartolomeis, Carmine Tomasetti, Felice Iasevoli · 2015 · CNS Drugs
Network interactions in schizophrenia - therapeutic implications.
A. Carlsson, N. Waters, S. Waters, M. Carlsson · 2000 · Brain research. Brain research reviews
Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study
A. Strafella, J. Ko, J. Grant, Maria Fraraccio, O. Monchi · 2005 · European Journal of Neuroscience
Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor
Stefano Espinoza, Ali Salahpour, Bernard Masri, Tatyana D. Sotnikova, Mirko Messa, Larry S. Barak, Marc G. Caron, Raul R. Gainetdinov · 2011 · Molecular Pharmacology
The placebo effect in neurological disorders
de la Fuente-Fernández, Raúl, Schulzer, Michael, Stoessl, A Jon · 2002 · The Lancet Neurology
Patients with Schizophrenia have a Reduced Neural Response to Both Unpredictable and Predictable Primary Reinforcers
Waltz, James A, Schweitzer, Julie B, Gold, James M, Kurup, Pradeep K, Ross, Thomas J, Jo Salmeron, Betty, Rose, Emma Jane, McClure, Samuel M, Stein, Elliot A · 2009 · Neuropsychopharmacology
Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring
Marie‐Ève Fortier, Ridha Joober, Giamal N. Luheshi, Patricia Boksa · 2003 · Journal of Psychiatric Research
An integrated view of pathophysiological models of schizophrenia
Gary E. Duncan, Brian Sheitman, Jeffery A. Lieberman · 1999 · Brain Research Reviews
PET kinetic analysis—compartmental model
H. Watabe, Y. Ikoma, Y. Kimura, M. Naganawa, M. Shidahara · 2006 · Annals of Nuclear Medicine
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Stefano Aringhieri, Marco Carli, Shivakumar Kolachalam, Valeria Verdesca, Enrico Cini, Mario Rossi, Peter James McCormick, Giovanni Umberto Corsini, Roberto Maggio, Marco Scarselli · 2018 · Pharmacology & Therapeutics
The dopaminergic basis of human behaviors: A review of molecular imaging studies
Alice Egerton, Mitul Ashok Mehta, Andrew J. Montgomery, Julia Lappin, Oliver David Howes, Suzanne Reeves, Vincent J. Cunningham, Paul M. Grasby · 2009 · Neuroscience & Biobehavioral Reviews
Reducing Prefrontal Gamma-Aminobutyric Acid Activity Induces Cognitive, Behavioral, and Dopaminergic Abnormalities That Resemble Schizophrenia
Enomoto, Takeshi, Tse, Maric T., Floresco, Stan B. · 2011 · Biological Psychiatry
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies
Abi-Dargham, Anissa, Laruelle, Marc · 2005 · European Psychiatry
Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover
R. de la Fuente-Fernández, Jian-Qiang Lu, V. Sossi, S. Jivan, M. Schulzer, J. E. Holden, Chong S. Lee, Thomas J. Ruth, D. Calne, A. Stoessl · 2001 · Annals of Neurology
Schizophrenia: from dopaminergic to glutamatergic interventions
Marc A. Laruelle · 2014 · Current Opinion in Pharmacology
Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?
S. Laviolette · 2007 · Schizophrenia bulletin
Drug-Induced Psychosis: How to Avoid Star Gazing in Schizophrenia Research by Looking at More Obvious Sources of Light
Alessandra Paparelli, Marta Di Forti, Paul D. Morrison, Robin M. Murray · 2011 · Frontiers in Behavioral Neuroscience
Sleep disturbance in schizophrenia
J. Monti, D. Monti · 2005 · International Review of Psychiatry
Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia
Steullet, P., Neijt, H.C., Cuénod, M., Do, K.Q. · 2006 · Neuroscience
The Relationship between Dorsolateral Prefrontal Neuronal N-Acetylaspartate and Evoked Release of Striatal Dopamine in Schizophrenia
A. Bertolino, A. Breier, J. Callicott, C. Adler, V. Mattay, Maxim Shapiro, J. Frank, D. Pickar, D. Weinberger · 2000 · Neuropsychopharmacology
A Novel α5GABAAR-Positive Allosteric Modulator Reverses Hyperactivation of the Dopamine System in the MAM Model of Schizophrenia
Kathryn M. Gill, Daniel J. Lodge, James Minton Cook, Shamim Aras, Anthony A. Grace · 2011 · Neuropsychopharmacology
Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents
Elman, Igor, Borsook, David, Lukas, Scott E · 2006 · Neuropsychopharmacology
Mechanism of action of antipsychotic drugs: From dopamine D2 receptor antagonism to glutamate NMDA facilitation
Marc A. Laruelle, William Gordon Frankle, Rajesh Narendran, Lawrence S. Kegeles, Anissa Abi‐Dargham · 2005 · Clinical Therapeutics
Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans
R. Hilker, J. Voges, M. Ghaemi, R. Lehrke, J. Rudolf, A. Koulousakis, K. Herholz, K. Wienhard, V. Sturm, W. Heiss · 2003 · Movement Disorders
Imaging biomarkers in Parkinson's disease.
D. Brooks, N. Pavese · 2011 · Progress in neurobiology
Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson’s disease
Michel Cyr, Frédéric Calon, Marc Morissette, Thérèse Di Paolo · 2002 · Journal of Psychiatry and Neuroscience
Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study
Yoshitaka Kumakura, Paul D. Cumming, Ingo Vernaleken, Hans‐Georg Buchholz, Thomas Siessmeier, Andreas Heinz, Thorsten Kienast, Peter Bartenstein, Gerhard Gründer · 2007 · Journal of Neuroscience
Functional neuroimaging in schizophrenia: diagnosis and drug discovery
Philip K. McGuire, Oliver David Howes, James M. Stone, Paolo Fusar‐Poli · 2008 · Trends in Pharmacological Sciences
Schizophrenia: From developmental deviance to dopamine dysregulation
Robin M. Murray, Julia Lappin, Marta Di Forti · 2008 · European Neuropsychopharmacology
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis
Oliver David Howes, Andrew J. Montgomery, Marie‐Claude Asselin, Robin M. Murray, Paul M. Grasby, Philip K. McGuire · 2007 · The British Journal of Psychiatry
Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders
Martin F. Sarter, John P. Bruno · 1999 · Trends in Neurosciences
Imaging in Parkinson’s Disease: The Role of Monoamines in Behavior
David James Brooks, Paola P. Piccini · 2006 · Biological Psychiatry
Sleep and circadian rhythm dysregulation in schizophrenia
Monti, Jaime M., BaHammam, Ahmed S., Pandi-Perumal, Seithikurippu R., Bromundt, Vivien, Spence, D. Warren, Cardinali, Daniel P., Brown, Gregory M. · 2013 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Current perspectives on incentive salience and applications to clinical disorders
Olney, Jeffrey J, Warlow, Shelley M, Naffziger, Erin E, Berridge, Kent C · 2018 · Current Opinion in Behavioral Sciences
Modeling psychiatric disorders for developing effective treatments
Kaiser, Tobias, Feng, Guoping · 2015 · Nature Medicine
Endogenous dopamine release after pharmacological challenges in Parkinson's disease
P. Piccini, N. Pavese, D. Brooks · 2003 · Annals of Neurology
Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine
Richard C. Saunders, Bhaskar S. Kolachana, Jocelyne Bachevalier, Daniel R. Weinberger · 1998 · Nature
Within-Subject Comparison of [ 11 C]-( + )-PHNO and [ 11 C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans
Paul Shotbolt, Andri C. Tziortzi, Graham E. Searle, Alessandro Colasanti, Jasper van der Aart, Sergio Abanades, Christophe Plisson, Sam R. Miller, Mickaël Huiban, John D. Beaver et al. · 2011 · Journal of Cerebral Blood Flow & Metabolism
Stress-Induced Dopamine Release in Humans at Risk of Psychosis: a [11C]Raclopride PET Study
Alexandra Soliman, G. O'Driscoll, J. Pruessner, A. Holahan, I. Boileau, Danny Gagnon, A. Dagher · 2008 · Neuropsychopharmacology
In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride
R. Narendran, D. Hwang, M. Slifstein, P. Talbot, D. Erritzoe, Y. Huang, Thomas B. Cooper, D. Martinez, Lawrence S. Kegeles, A. Abi-Dargham et al. · 2004 · Synapse
Applications of positron emission tomography (PET) in neurology
Yen Tai · 2004 · Journal of Neurology Neurosurgery & Psychiatry
What We Know: Findings That Every Theory of Schizophrenia Should Explain
Angus W. MacDonald, S. Charles Schulz · 2009 · Schizophrenia Bulletin
A network of dopaminergic gene variations implicated as risk factors for schizophrenia.
Michael E. Talkowski, G. Kirov, M. Bamne, L. Georgieva, G. E. Torres, Hader A. Mansour, K. Chowdari, V. Milanova, J. Wood, L. McClain et al. · 2008 · Human Molecular Genetics
Cortical Cholinergic Transmission and Cortical Information Processing in Schizophrenia
Sarter, M. · 2005 · Schizophrenia Bulletin
An Evolutionary Framework to Understand Foraging, Wanting, and Desire: The Neuropsychology of the SEEKING System
Jason S. Wright, Jaak Panksepp · 2012 · Neuropsychoanalysis
Deficits in Dopamine D2 Receptors and Presynaptic Dopamine in Heroin Dependence: Commonalities and Differences with Other Types of Addiction
Diana Martínez, Phillip A. Saccone, Fei Liu, Mark Slifstein, Daria Orlowska, Alex Grassetti, Stephanie Cook, Allegra I. Broft, Ronald Van Heertum, Sandra D. Comer · 2011 · Biological Psychiatry
Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities
Sarah M. Clinton, James H. Meador‐Woodruff · 2003 · Schizophrenia Research